Sectors
GLMD
Galmed Pharmaceuticals Ltd.
4.12
2 x 3.06
2 x 5.37
bid
ask
+
0.04
1.10%
2 @ 07:46 PM
4.26 +0.14 (3.40%)
| Ytd | 448.60% | |
| 1y | 224.41% |
4.03
day range
4.16
3.29
52 week range
13.20
| Open | 4.04 | Prev Close | 4.08 | Low | 4.03 | High | 4.16 | Mkt Cap | 4.29M |
| Vol | 7.21K | Avg Vol | 101.23K | EPS | -16.48 | P/E | N/A | Forward P/E | -2.94 |
| Beta | 0.80 | Short Ratio | 0.27 | Inst. Own | 0.48% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 09-01 | 50-d Avg | 4.46 | 200-d Avg | 5.48 | 1yr Est | 12.00 |
| Income Statement | |||
| Operating Expenses | 2.04M | ||
| Research and Development Expense | 1.36M | ||
| Selling, General and Administrative Expense | 684.00K | ||
| Operating Income | -2.04M | ||
| Interest Expense | -134.00K | ||
| Net Income | -1.91M | ||
| Net Income Common Stock | -1.91M | ||
| Net Income Common Stock (USD) | -1.91M | ||
| Consolidated Income | -1.91M | ||
| Earnings per Basic Share | -2.32 | ||
| Earnings per Basic Share (USD) | -2.32 | ||
| Earnings per Diluted Share | -2.32 | ||
| Earning Before Interest & Taxes (EBIT) | -2.04M | ||
| Earning Before Interest & Taxes (USD) | -2.04M | ||
| Weighted Average Shares | 823.93K | ||
| Weighted Average Shares Diluted | 823.93K | ||
| Balance Sheet | |||
| Cash and Equivalents | 1.73M | ||
| Cash and Equivalents (USD) | 1.73M | ||
| Investments | 13.85M | ||
| Investments Current | 13.85M | ||
| Trade and Non-Trade Receivables | 451.00K | ||
| Current Assets | 16.03M | ||
| Total Assets | 16.03M | ||
| Current Liabilities | 2.08M | ||
| Total Liabilities | 2.08M | ||
| Accumulated Retained Earnings (Deficit) | -212.69M | ||
| Accumulated Other Comprehensive Income | -383.00K | ||
| Shareholders Equity | 13.95M | ||
| Shareholders Equity (USD) | 13.95M | ||
| Trade and Non-Trade Payables | 2.08M | ||
| Cash Flow | |||
| Net Cash Flow / Change in Cash & Cash Equivalents | -2.38M | ||
| Net Cash Flow from Investing | 152.00K | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 152.00K | ||
| Net Cash Flow from Operations | -2.54M | ||
| Share Based Compensation | 156.00K | ||